Figure 2From: Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: A randomised controlled trial in patients with osteoarthritis Kaplan-Meier estimates of the probability (%) of premature discontinuation for any reason (ITT population). o.d. = once daily; b.i.d. = twice daily; ITT = intention-to-treat.Back to article page